Wikidata

(Q85351393)

English

A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis

scientific article published on 19 September 2014

In more languages

Statements

title
A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25242558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25242558%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q85351393&oldid=1538380915"